Chief Executive Officer
Peter brings more than 20 years of executive leadership and operational experience to Recombinant, and his background in governance and compliance provides a unique blend of skills to Recombinant's clients. Under Peter's leadership Recombinant has become a trusted partner and advisor to major healthcare and life sciences organizations, with a successful track record of conceiving and delivering creative solutions to complex challenges in the secondary use of healthcare information.
In addition to his executive role at Recombinant, Mr. Emerson is active in client engagements for the company. He provides consulting and facilitation expertise on a variety of issues, including legal and regulatory issues relating to formation of multi-entity translational research collaborative networks. He also specializes in data governance, patient privacy, and research consent issues associated with data sharing among institutions as well as complex HIPAA and IRB issues raised by initiatives to share data across organizational boundaries within institutions, particularly in using patient care data for research.
Prior to joining Recombinant, Peter held corporate leadership, operational, and general counsel positions with a number of technology companies and practiced healthcare and corporate law with firms in Boston and Washington, D.C.
Peter is a graduate of the Harvard Law School, and holds an MA from Oxford University, and a BA from the University of Pennsylvania.
Co-Founder and Managing Director, Data Warehousing
Aaron has been a leader in data warehousing technology for over 25 years and launched Recombinant to apply this technology at hospitals, provider groups, and other healthcare organizations to accelerate the translation of scientific discoveries into new treatments and to improve clinical patient care operations.
Through his work in the healthcare domain, Aaron has become a recognized expert in clinical data repositories, secondary uses of healthcare data, and the implementation and use of the open source i2b2 translational research informatics platform.
Aaron is active in business development, and provides consulting expertise and executive leadership on Recombinant data warehousing projects at Academic Medical Centers and large provider organizations. Like other members of the Recombinant team, Aaron is also a valuable resource for the Recombinant client community and others active in biomedical informatics, making connections to facilitate collaboration and discussion among people and institutions facing similar issues and working on related projects.
Aaron has long been involved with innovative clinical data projects, including the Research Patient Data Registry (RPDR) at Massachusetts General Hospital and the Quality Data Warehouse at Partners HealthCare, and continuing with current projects guiding Recombinant clients in leveraging their clinical data resources for research and operational improvement. Prior to founding Recombinant, Aaron was an information technology consultant and entrepreneur in multiple industries, including financial services and consumer products, before focusing on healthcare.
Aaron earned a BA at Middlebury College and an MBA from Columbia University.
Managing Director, Services
Gregg leads Recombinant's delivery teams, which provide product implementations, technical development, consulting, and support services to the growing Recombinant client community. Gregg's background includes extensive experience managing major IT projects and client services in healthcare and other domains, based on his expertise in technology delivery, strategic planning, and operations optimization.
Gregg was previously Senior Director of Account Management at NaviNet, the largest real-time healthcare communications network in the U.S., which securely links hundreds of thousands of healthcare professionals, health plans, and industry partners. As the relationship owner for NaviNet health plan clients, Gregg marshaled and led multiple cross-functional teams responsible for project delivery, customer support, and user services. He has also held senior roles at Edgewater Technology, one of the largest IT consulting firms in New England, where he managed large-scale technology integration projects for clients.
Gregg earned a BS in Finance with a concentration in Quantitative Analysis, graduating Cum Laude from Babson College.
Managing Director, Clinical Operations and Genomics
Mark comes to Recombinant with an extensive background in health care management consulting, general business operations, operations design and restructuring, and startup development and venture finance. He is currently General Manager for Recombinant’s Provider/ACO vertical and has been engaged in a variety of Recombinant’s data governance, strategy, and organizational leadership projects, particularly focusing on personalized medicine, data warehousing for lean six sigma, and ACO tool development.
Prior to Recombinant, Mark was a turnaround and operations restructuring management consultant with over 15 years of experience in healthcare services and medical products operations and consulting at Arthur D. Little, Bain & Company, and APM/CSC, Inc. A champion of the New Product Lab (NPL) at the University of Chicago, Mark is best known for introducing the NPL's hyper-brainstorming techniques and lean six sigma methods to the restructuring of major medical centers and clinics.
At APM, his operations and business process restructuring teams led organizational change and governance projects that brought over $250 million in annual operating improvement to more than a dozen medical centers, faculty practice plans, and integrated multi-specialty clinics. Mark’s clients span the health care continuum: major for-profit & not-for-profit hospitals, academic medical centers, community hospitals, rural hospitals, faculty practice plans, integrated multi-specialty clinics, and long term care chains (Manor Care, Hillhaven/Kindred, HealthTrust Hospitals, Fairview Health, UCLA, SUNY-Stonybrook, and the Mayo Clinic. At Arthur D. Little he consulted in market and competitive strategy for major medical products, devices, and pharmaceutical companies.
Mark’s healthcare operating experience includes roles as COO of PQC, (Physicians Quality Care, Inc.) a $100M Physician Practice Management company, and COO/turnaround leader of TravCorps Corporation, a venture-backed, medical, temporary staffing company. TravCorps' profits and revenues more than tripled under his leadership and sold for more than $100 million creating a 25X return to shareholders. He has also served as the President or CEO of one medical device and two biotech startup companies.
Earlier, Mark was the co-founder of the innovative hospital chain Health Resources Corp. (IPO NASDAQ-HRCA 1985) and the creator of its HealthTex “informed choice” prevention product--the first of its kind, on-line consumer health/EMR storage website that he launched on CompuServe in 1983. Mark also organized the first privately sponsored Senate hearings on Disease Prevention and Health Promotion in 1981.
Mark is an advisory board member of the Gene Partnership Project (Children’s Hospital Boston) and a Technical Advisory Group member to CIMIT (Center for Integration of Medicine and Innovative Technology, a Harvard/MIT/Draper Lab consortium). He also serves on the Dana-Farber Cancer Institute’s Basic Science Visiting Committee and is the Director of the not-for-profit, Clinical Genomics Consortium. He received both his BA – Medical Anthropology and MBA from the University of Chicago.
David Hardison, PhD
Managing Director, Health Sciences
David brings more than 30 years of leadership experience and knowledge at the intersection of biopharmaceutical R&D, healthcare delivery, performance improvement, and information technology. David focuses on strategic consulting and business development for both life sciences companies and healthcare providers, and is also responsible for overseeing Recombinant's growing presence in the European Union.
Before joining Recombinant, David held executive-level positions with major consulting and provider organizations, focused on end-to-end information integration to enable improved health outcomes. Most recently, he was Vice President and Chief Health Scientist for SAIC (Science Applications International Corporation), where he played a significant role in building that firm's Healthcare and Life Sciences business. In senior positions at several well-known provider organizations, including Novant Health, Wheaton Franciscan Services, Quorum Health Resources, and Hospital Corporation of America, David led major initiatives in IT strategic plans and enterprise-wide IT-enabled quality and clinical performance improvement. David began his career at Eli Lilly where he was a key member of the team that brought Prozac to the global market.
David is active in a variety of industry organizations and advisory boards, and has served as a Board Member and Chairman of CDISC (Clinical Data Interchange Standards Consortium). He has also published numerous articles in journals on healthcare information technology in clinical research and quality improvement.
David earned a PhD in Biostatistics with minors in Epidemiology and Data Management for the University of North Carolina School of Public Health, and a BS in Mathematics and Computer Science from Vanderbilt University, graduating Magna Cum Laude with High Honors in Mathematics.
Chief Technology Officer
Dan is a software veteran with a proven track record of providing valuable and innovative decision support systems to large, complex organizations. Dan leads Recombinant's strategy, product planning, and development, and is very active in Recombinant client engagements with a focus on translational research, bioinformatics and innovative approaches to data capture, analysis, and reporting for clinical quality and performance improvement. He has conceived and delivered a wide range of successful web-based analytical solutions for Recombinant clients including clinical performance dashboards, analytic and reporting solutions for performance metrics such as Meaningful Use and PQRS, and clinical research and disease management registry systems.
Dan's combination of technical and scientific knowledge is the source of innovative approaches to analytical platforms for healthcare data. His background in chemistry and biology, combined with his experience in clinical data warehousing and analytics, gives Dan insight into both genomic and clinical data, as well as their practical intersection for researchers. This led to creation of the tranSMART platform in partnership with Recombinant client Johnson & Johnson, providing scientists with a self-service portal that integrates clinical, genomic, and literature data with powerful search and analysis tools, offering pharma/biotech companies and academic centers a unique way to leverage data and improve research productivity.
Prior to co-founding Recombinant Data, Dan founded ChannelWave, a company that pioneered PRM (Partner Relationship Management) and ecommerce applications. His vision and leadership at ChannelWave helped to create a business delivering demand chain optimization solutions to clients including Verizon, HP, RIM/Blackberry, Arrow Electronics, and Hyundai.
Dan earned a BS in Chemistry and Biology from MIT in 1995 and is an active member of HDWA (Healthcare Data Warehousing Association) and AMIA (American Medical Informatics Association).
Bruce D. Johnson
Managing Director, Data Architecture, Strategy, and Governance
Bruce provides Recombinant clients with strategic guidance on data architecture, warehousing, and data governance based on more than 25 years of experience as an IT professional and his recognized expertise on the unique issues of governance and data warehousing in healthcare.
Bruce's combination of thought leadership in the governance, definition, and stewardship of data and technology expertise has been critical to the success of Recombinant engagements with clients such as Johnson & Johnson, Piedmont Healthcare, MaineHealth, the University of Minnesota, and Bassett Healthcare. Under Bruce's leadership, Recombinant has provided these and other clients with data strategy roadmaps that paved the way for the practical development and implementation of effective, right-sized governance and innovative solutions in the secondary use of healthcare data. In addition, Bruce's expertise in data modeling and clinical data warehousing has been very valuable in conducting assessments of existing data warehouses for Recombinant clients, and in the development of Recombinant's Data Trust Clinical Data Warehouse product.
Prior to joining Recombinant, Bruce led the definition and establishment of the Mayo Clinic Life Sciences Systems and Enterprise Data Trust data warehouses. These efforts required building support and trust of executive and medical leaders, defining enterprise meta data, data governance, and an enterprise data model, as well as establishing the staffing, tools, processes, and approaches required for success. Bruce's expertise in large scale data warehousing, decision support / business intelligence, application architecture, business analysis, and software vendor selection is based on his experience in many industries in addition to Healthcare, including Finance, Transportation, Retail, and Travel.
Bruce earned a BS in Computer Science in 1986 at DeVry Institute of Technology in Columbus, Ohio. He is an active member of HDWA (Healthcare Data Warehousing Association) and writes a monthly column for the Enterprise Information Management Institute. Copies of his articles can be found at http://www.EIMInstitute.org.
Managing Director, Health Systems Solutions
Michael Kamerick is a recognized expert in biomedical informatics and clinical & translational science, bringing a strong information technology background and experience in healthcare data strategy, governance, and security to Recombinant clients. Michael focuses on strategic consulting and business development, and continues to be active in the CTSA (Clinical and Translational Sciences Awards) and biomedical informatics communities. He also translates his experience and knowledge into product direction as Recombinant develops leading edge data platforms and research solutions for academic medical centers.
Prior to joining Recombinant, Michael was the Director of Academic Research Systems at UCSF (University of California, San Francisco) and Co-Director of Biomedical Informatics at the UCSF Clinical and Translational Science Institute. During his tenure at UCSF, Michael led the development and execution of a variety of initiatives to improve the governance, regulatory compliance, security, and technical infrastructure for research data. Michael's background also includes commercial and entrepreneurial experience with a number of information technology and venture capital firms.
As a prominent member of the biomedical informatics community, Michael served for four years as Chair of the Research Data Repositories group for the national CTSA Informatics Committee, and is an active member of AMIA (American Medical Informatics Association), and other organizations focused on healthcare data and translational research.
Michael earned a BS in Computer Science from San Francisco State University, graduating Magna Cum Laude, and is a member of Phi Beta Kappa.
Managing Director, Health Systems Consulting
Jason brings more than 26 years of healthcare information technology and business intelligence experience to Recombinant. Jason focuses on solving the challenges healthcare organizations encounter leveraging their investments in electronic data to deliver meaningful information to the organization. His deep experience strengthens Recombinant’s ability to deliver enterprise data warehousing solutions and advisory services.
Prior to joining Recombinant, Jason was a Partner in the Health Care Group at Kurt Salmon Associates He served as a strategic advisor to healthcare organizations pursuing their business intelligence planning, technology evaluation, architecture design, and implementation program management efforts. He has also held management positions supporting analytical services, data warehousing, and business intelligence environments for Columbia Presbyterian Medical Center and the NYC Health & Hospitals Corporation.
Jason earned his BBA in Computer Systems Design and his MBA in Health Care Administration from the City University of New York, Baruch College.
Chief Operating Officer
Shelley is a seasoned business executive who has overseen Recombinant's growth from day one. In her role as COO, Shelley is responsible for Finance, Human Resources, IT Services, and Facilities Management at Recombinant. She has developed a strong team of professionals and internal infrastructure to support Recombinant's rapid expansion, and has overseen the company's profitable growth and transition from a regional consulting and software development firm to a national, product-oriented company with a growing presence in the European Union.
Prior to joining Recombinant Shelley was CEO of CallBack Software, a CRM (Customer Relationship Management) company, growing sales revenues by 50% and leading it to three of its most profitable years.
Shelley earned a BA in Economics at the University of Vermont.